πŸ‡ΊπŸ‡Έ FDA
Patent

US 7807689

Dipeptidyl peptidase inhibitors

granted A61PA61P13/08A61P13/12

Quick answer

US patent 7807689 (Dipeptidyl peptidase inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
51
CPC classes
A61P, A61P13/08, A61P13/12, A61P15/08, A61P15/16